| |
| |
|
| Insider
Information: |
Maraganore John |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
263,534 |
|
|
Indirect Shares
|
6,153,633 |
|
|
| Direct
Value |
$35,430,768 |
|
|
|
Indirect Value
|
$14,183,372 |
|
|
| Total
Shares |
6,417,167 |
|
|
| Total
Value |
$49,614,140 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alnylam Pharmaceuticals Inc |
ALNY |
Chief Executive Office... |
2021-12-22 |
227,663 |
2021-12-22 |
3,133 |
Premium* |
|
|
Regulus Therapeutics Inc. |
RGLS |
Director, 10% Owner |
2012-10-10 |
0 |
2012-10-10 |
6,150,500 |
Premium* |
|
|
Agios Pharmaceuticals Inc |
AGIO |
Director |
2022-05-20 |
30,028 |
|
0 |
Premium* |
|
|
Bluebird Bio, Inc. |
BLUE |
Director |
2017-09-14 |
5,843 |
2014-07-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
154 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2013-07-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
36,000 |
|
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2013-07-24 |
4 |
B |
$18.00 |
$149,994 |
D/D |
8,333 |
44,333 |
2.39 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2014-04-29 |
4 |
B |
$44.00 |
$99,000 |
D/D |
2,250 |
46,583 |
2.39 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2014-06-23 |
4 |
B |
$43.98 |
$101,154 |
D/D |
2,300 |
48,883 |
2.39 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2014-12-16 |
4 |
B |
$110.75 |
$200,015 |
D/D |
1,806 |
50,689 |
2.39 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2015-04-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
515 |
50,174 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2015-06-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
410 |
49,764 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2018-09-11 |
4 |
S |
$72.52 |
$986,129 |
D/D |
(13,555) |
36,209 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2018-09-12 |
4 |
S |
$71.74 |
$1,015,982 |
D/D |
(14,162) |
22,047 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2018-09-12 |
4/A |
S |
$0.00 |
$0 |
D/D |
(0) |
36,209 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2019-05-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,400 |
37,609 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2019-06-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,000 |
32,609 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2020-02-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
4,315 |
28,294 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2020-05-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,878 |
30,172 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2021-02-04 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,415 |
26,757 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2021-05-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,686 |
28,443 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2022-05-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,585 |
30,028 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President and CEO |
• • – |
2004-08-24 |
4 |
B |
$4.43 |
$5,338 |
D/D |
1,200 |
0 |
2.81 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President and CEO |
• • – |
2004-08-25 |
4 |
B |
$4.79 |
$33,172 |
D/D |
6,840 |
8,040 |
2.81 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President and CEO |
• • – |
2004-11-19 |
4 |
B |
$6.00 |
$7,380 |
D/D |
1,230 |
9,270 |
2.81 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President & CEO |
• • – |
2006-05-12 |
4 |
AS |
$15.01 |
$428,070 |
D/D |
(28,313) |
18,457 |
|
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President & CEO |
• • – |
2006-05-12 |
4 |
OE |
$0.48 |
$17,813 |
D/D |
37,500 |
46,770 |
|
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President & CEO |
• • – |
2006-05-12 |
4 |
AS |
$14.94 |
$206,933 |
D/D |
(13,322) |
5,135 |
|
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
CEO |
• • – |
2007-06-28 |
4 |
AS |
$15.78 |
$320,253 |
D/D |
(20,069) |
17,431 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
CEO |
• • – |
2007-06-28 |
4 |
OE |
$0.48 |
$17,813 |
D/D |
37,500 |
37,500 |
0 |
- |
|
154 Records found
|
|
Page 1 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
